IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.
iVIEW Therapeutics's investors include Cowin Capital, Prox Ventures, Chongqing Dianshi Medical Equipment Fund, Hangzhou Jiurun Investment, Hangzhou Yilu Medical.
iVIEW Therapeutics is headquartered in Doylestown, United States.
IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.
iVIEW Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iVIEW Therapeutics — Funding & Investors." VCBacked, January 17, 2025, https://www.vcbacked.co/company/iview-therapeutics. Accessed November 12, 2026.
VCBacked. (2025). iVIEW Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/iview-therapeutics
{{cite web |title=iVIEW Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iview-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at iVIEW Therapeutics? Request a listing update